Showing results (431-440 of 782) with videos related to
Sort By:
Pageof 79
European Journal of Haematology|October 14, 2011
The Medical Research Council Myeloma IX trial: the impact on treatment paradigmsPaul G Richardson, Jacob P Laubach, Robert L Schlossman, et al.British Journal of Haematology|May 4, 2011
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 studyPaul G Richardson, Asher A Chanan-Khan, Sagar Lonial, et al.Blood|September 11, 2014
Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche modelMichaela R Reagan, Yuji Mishima, Siobhan V Glavey, et al.Leukemia Research|April 16, 2013
Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myelomaPaul G Richardson, Constantine S Mitsiades, Jacob P Laubach, et al.Blood|May 31, 2002
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myelomaRoberto Bellucci, Edwin P Alyea, Edie Weller, et al.Blood|March 14, 2014
MYD88-independent growth and survival effects of Sp1 transactivation in Waldenstrom macroglobulinemiaMariateresa Fulciniti, Nicola Amodio, Rajya Lakshmi Bandi, et al.Gastroenterology|May 13, 2023
Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal AdenocarcinomaSubodh Kumar, Jiangning Zhao, Srikanth Talluri, et al.Experimental Hematology|December 3, 2014
Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatmentGang An, Chirag Acharya, Shuhui Deng, et al.Cancers|July 2, 2021
Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple MyelomaYanira Ruiz-Heredia, Alejandra Ortiz-Ruiz, Mehmet K Samur, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionMark Bustoros, Romanos Sklavenitis-Pistofidis, Jihye Park, et al.Pageof 79